To add a bio or update investment portfolio click update information.
Hargreave Hale AIM VCT: Investment Portfolio & Startup News
Hargreave Hale AIM VCT
Investment Portfolio
52North
29 Sept 2026
52North raises £3.2m in funding led by Macmillan Cancer Support to support urgent cancer care diagnostics
52North is a medical technology spin-out from the University of Cambridge developing the Aster biomarker platform and Neutrocheck, a rapid finger-prick blood test. Neutrocheck supports remote triaging of chemotherapy patients at risk of neutropenic sepsis to reduce unnecessary emergency hospital visits.
Qureight
29 Jul 2026
Qureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Qureight is an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials, with a focus on lung and heart disease. Deep learning models built on 3D chest imaging quantify structural changes that indicate disease progression, giving biopharma partners measurable endpoints during trials.
Hargreave Hale AIM VCT
More venture news
- 26 Oct 2026
NousNous raises £13m in funding led by Heartcore Capital and Mosaic Ventures for an AI agent that manages household bills and admin
EquityConsumer - 19 Oct 2026
FrugaFruga secures a £1m in funding led by PXN Ventures to lower insurance renewal premiums through open banking
EquityFintech - 13 Oct 2026
SainapticSainaptic raises £1m in funding led by Cornerstone VC and Ufi Ventures for AI-assisted marking of vocational and professional qualifications
EquityEducation
